Wykorzystanie macierzy DNA oraz RNA w identyfikacji markerów onkogenezy u ssaków

• Autorzy: Kempisty B. , Zawierucha P. , Nowicki M.

Warianty tytułu

EN

Using of DNA and RNA microarrays in order to identify oncogenesis markers in mammals

• Języki publikacji: PL

Abstrakty

EN

In recent years an increased number of diagnosed cancers in mammals have been noted, mainly in dogs, and has lead to intensive research based on the causes and course of cancers in animals. The development of molecular biological techniques, statistics and bioinformatics has made possible the development of new diagnostic methods. The DNA microarrays is a technique that is prepared for the identification of new mutations within the scale of the whole genome as well as in the determination of the frequency of single nucleotide polymorphisms (SNP). A consequence of the development of this method is the creation of RNA microarrays based on transcriptomics technology. Using both of these methods in the scale of whole genome and/or transcriptome leads to describing the causes of oncogenesis induction as well as suggests more efficient methods of therapeutic treatments. In this article the methodological characteristics and possible practical application of DNA and RNA microarrays in research on mammalian oncogenesis has been presented.

Słowa kluczowe

PL

ssaki; onkogeneza; markery nowotworowe; mutacje; identyfikacja; mikromacierze; genotypowanie; polimorfizm pojedynczego nukleotydu; profilowanie ekspresji genow; transkryptomika

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2011
• Tom: 67
• Numer: 08
• Opis fizyczny: s.527-530,bibliogr.

Twórcy

autor

Kempisty B.

• Katedra i Zakład Histologii i Embriologii, Wydział Lekarski II, Uniwersytet Medyczny w Poznaniu, ul.Święcickiego 6, 60-781 Poznań

autor

Zawierucha P.

autor

Nowicki M.

Bibliografia

• 1. Alon U., Barkai N., Notterman D. A., Gish K., Ybarra S., Mack D., Levine A. J.: Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natal. Acad. Sci. USA 1999, 96, 6745-6750.
• 2. Altman R. B., Raychaudhuri S.: Whole-genome expression analtsis: Challenges beyond clustering. Curr. Opin. Struct. Biol. 2001, 11, 340-347.
• 3. Brazma A., Vilo J.: Gene expression data analysis. FEBS Lett 2000, 480, 17-24.
• 4. Brown M. P., Grundy W. N., Lin D., Cristianini N., Sugnet C. W., Furey T. S., Ares M. Jr, Haussler D.: Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc. Natal. Acad. Sci. USA 2000, 97, 262-267.
• 5. Cazaux C.: Genetic instability as a driver for oncogenesis. Bull Cancer 2010, 97, 1241-1251.
• 6. Chechetkin V. R., Turygin A. Y., Proudnikov D. Y., Prokopenko D. V., Kirillov E. V., Mirzabekov A. D.: Sequencing by hybridization with the generic 6-mer oligonucleotide microarray: An advanced scheme for data processing. J. Biomol. Struct. Dyn. 2000, 18, 83-101.
• 7. Eisen M. B., Spellman P. T., Brown P. O., Botstein D.: Cluster analysis and display of genome-wide expression patterns. Proc. Natal. Acad. Sci. USA 1998, 95, 14863-14868.
• 8. Fabbri M., Calin G. A.: Epigenetics and miRNAs in human cancer. Adv Genet. 2010, 70, 87-99.
• 9. Favis R., Day J. P., Gerry N. P., Phelan C., Narod S., Barany F.: Universal DNA array detection of small insertions and deletions in BRCA1 and BRCA2. Nat. Biotechnol. 2000, 18, 561-564.
• 10. Hacia J. G., Brody L. C., Chee M. S., Fodor S. P., Collins F. S.: Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two-colour fluorescence analysis. Nat. Genet. 1996, 14, 441-447.
• 11. Hacia J. G., Edgemon K., Fang N., Mayer R. A., Sudano D., Hunt N., Collins F. S.: Oligonucleotide microarray based detection of repetitive sequence changes. Hum. Mutat. 2000, 16, 354-363.
• 12. Kallioniemi A., Kallioniemi O. P., Sudar D., Rutovitz D., Gray J. W., Waldman F., Pinkel D.: Comperative genomic hybridization for malecular cytogenic analysis of solid tumors. Science 1992, 258, 818-821.
• 13. Lam C. W., Lau K. C., Tong S. F.: Microarrays for personalized genomic medicine. Adv. Clin. Chem. 2010, 52, 1-18.
• 14. Lindblad-Toh K., Tanenbaum D. M., Daly M. J., Winchester E., Lui W. O., Villapakkam A., Stanton S. E., Larsson C., Hudson T. J., Johnson B. E., Lander E. S., Meyerson M.: Loss-of-heterozygosity analysis of small-cell lung carcinomas using single nucleotide polymorphism arrays. Nat. Biotechnol. 2000, 18, 1001-1005.
• 15. Liotta L., Petricoin E.: Molecular profiling of human cancer. Nat. Rev. Genet. 2000, 1, 48-56.
• 16. Mei R., Galipeau P. C., Prass C., Berno A., Ghandour G., Patil N., Wolff R. K., Chee M. S., Reid B. J., Lockhart D. J.: Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res. 2000, 10, 1126-1137.
• 17. Roses A. D.: Pharmacogenetics and the practice of medicine. Nature 2000, 405, 857-865.
• 18. Ross D. T., Scherf U., Eisen M. B., Perou C. M., Rees C., Spellman P., Iyer V., Jeffrey S. S., Van de Rijn M., Waltham M., Pergamenschikov A., Lee J. C., Lashkari D., Shalon D., Myers T. G., Weinstein J. N., Botstein D., Brown P. O.: Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 2000, 24, 227-235.
• 19. Sapolsky R. J., Hsie L., Berno A., Ghandour G., Mittmann M., Fan J. B.: High-troughput polymorphism screening and genotyping with high-density oligonucleotide arrays. Genet. Anal. 1999, 14, 187-192.
• 20. Sherlock G.: Analysis of large-scale gene expression data. Curr. Opin. Immunol. 2000, 12, 201-205.
• 21. Slanar O., Zima T.: Pharmacogenetic aspects of current pharmacotherapy. Čas. Lek. Cesk. 2010, 149, 472-475.
• 22. Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E. S., Golub T. R.: Interpreting patterns of gene expression with self-organizing maps: Method and application to hematopoetic differentiation. Proc. Natal. Acad. Sci. USA 1999, 96, 2907-2912.
• 23. Velculescu V. E., Zhang L., Vogelstein B., Kinzler K. W.: Serial analysis of gene expression. Science 1995, 270, 484-487.
• 24. Voelkerding K. V., Dames S., Durtschi J. D.: Next generation sequencing for clinical diagnostics-principles and application to targeted resequencing for hypertrophic cardiomyopathy: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J. Mol. Diagn. 2010, 12, 539-551.
• 25. Wen W. H., Bernstein L., Lescallett J., Beazer-Barclay Y., Sullivan-Halley J., White M., Press M. F.: Comparison of TP53 mutations identified by oligonucleotide microarray and conventional DNA sequence analysis. Cancer Res. 2000, 60, 2716-2722.